AIIMS New Delhi has launched India's first portable bedside MRI system, a significant advancement in critical care and ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will publish its financial and ...
Restricting calorie intake in species such as mice, rhesus monkeys, and fruit flies has been shown to extend their lifespans. In some cases, these animals not only live longer, but are also free of ...
Regeneron rebounds from regulatory and clinical setbacks as Dupixent and pipeline catalysts fuel growth. Click here to read ...
Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...
A new set of drugs exploit a recently-revealed weakness in 'zombie-like' – or senescent – cells that could lead to new ...
As protectionism rises and the WTO falters, global trade is being rewired, not collapsing. New hubs centered on the European ...
Digital transformation and artificial intelligence (AI) in health care requires a range of safeguards and standards to work ...
Indian health delivery systems have been facing structural challenges for several decades. These challenges include chronic ...
Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...
Service Dog School of America reports that as mental health needs rise, nonclinical treatment options like service dogs, ...
Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care uveitis practice demonstrate outcomes consistent with results from the U.S. Phase 1b APEX study, supp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results